Finance

Lists
GMRS:NYSE
GMR Solutions Inc
$12.60
+0.24%
(+0.030) 1D
$12.60
0.00% (0.00)
After hours
Closed: Aug 28, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMRS...
Open
$12.67
High
$13.29
Low
$12.57
Mkt. cap
680.67M
Avg. vol.
631.99K
Volume
261.43K
P/E ratio
13.63
52-wk high
$15.98
52-wk low
$10.26
EPS
$0.92
No. of employees
34K
Open
$12.67
High
$13.29
Low
$12.57
Mkt. cap
680.67M
Avg. vol.
631.99K
Volume
261.43K
P/E ratio
13.63
52-wk high
$15.98
52-wk low
$10.26
EPS
$0.92
No. of employees
34K
About GMR Solutions Inc
CEO-
Employees34K
Founded2015
Headquarters-
SectorHealth care provider
Websiteglobalmedicalresponse.com
Analyst ratings
Based on 8 analysts giving stock ratings to GMRS in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for GMRS in the last 3 months.
Highest
Current $12.60
$30.00 (+138.10%)
Average
$18.86 (+49.68%)
Lowest
$14.00 (+11.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Buy
Maintained
$16.00
+27%
08/28/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$30.00
+138.1%
08/18/2026
A.J. Rice
UBS
Buy
Reiterated
$20.00
+58.7%
08/14/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
$14.00
+11.1%
08/14/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
-
-
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$20.00
+58.7%
08/13/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
$15.00
+19%
08/10/2026
James Kurek‏
UBS
Buy
Initiated
$20.00
+58.7%
06/08/2026
Daniel Grosslight
Citi
Buy
Initiated
$17.00
+34.9%
06/08/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$1.56 / $0.31
-599.97%miss
Revenue / Est. (USD)
1.49B / 1.47B
+1.40%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
1.37B
1.44B
1.46B
1.49B
Cost of goods sold
846.57M
855.23M
888.63M
1.06B
Cost of revenue
846.57M
855.23M
888.63M
1.06B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.65M
51.30M
42.98M
50.88M
Operating expense
320.03M
341.90M
339.53M
343.50M
Total operating expenses
1.17B
1.20B
1.23B
1.40B
Operating income
200.81M
244.88M
229.42M
85.85M
Other non operating income
922.00K
-5.17M
-556.00K
425.00K
EBT including unusual items
67.39M
122.29M
142.53M
-19.30M
EBT excluding unusual items
90.35M
131.47M
146.15M
9.86M
Income tax expense
29.37M
41.53M
36.20M
8.98M
Effective tax rate
43.58%
33.96%
25.39%
-46.53%
Other operating expenses
211.25M
218.09M
221.18M
215.67M
Net income
38.02M
80.76M
106.34M
-28.28M
Net profit margin
2.78%
5.60%
7.30%
-1.90%
Earnings per share
-
-
-
-1.56
Interest and investment income
-
-
-
-
Interest expense
-113.68M
-108.52M
-83.17M
-76.85M
Net interest expenses
-113.68M
-108.52M
-83.17M
-76.85M
Depreciation and amortization charges
75.13M
72.51M
75.37M
76.96M
EBITDA
275.93M
317.39M
300.69M
166.90M
Gain or loss from assets sale
16.78M
6.44M
1.08M
779.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps